col0,col1,col2,col3,col4,col5
trifluoperazine,trifluoperazine,Australian pregnancy category C,phenothiazine,407.164,Dopamine receptor D2
perphenazine,perphenazine,Australian pregnancy category C,phenothiazine,403.148511,Dopamine receptor D2
ergotamine,ergotamine,US pregnancy category X,ergotamines,581.264,5-hydroxytryptamine receptor 2A
trifluoperazine,trifluoperazine,US pregnancy category C,phenothiazine,407.164,5-hydroxytryptamine receptor 2A
perphenazine,perphenazine,US pregnancy category C,phenothiazine,403.148511,5-hydroxytryptamine receptor 2A
trifluoperazine,trifluoperazine,Australian pregnancy category C,phenothiazine,407.164,5-hydroxytryptamine receptor 2A
perphenazine,perphenazine,Australian pregnancy category C,phenothiazine,403.148511,5-hydroxytryptamine receptor 2A
diltiazem,diltiazem,US pregnancy category C,calcium channel blocker,414.161,Calcium voltage-gated channel subunit alpha1 C
